Prostate cancer decisions — 2025

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of exposure to herbicide agents during service and that the Veteran's prostate cancer did not have its onset in service or within a year of discharge from service.

The appeal was dismissed due to the Veteran's death while it was pending.

The appeal for service connection for prostate cancer, hearing loss, and glaucoma is dismissed as there are no remaining questions of law or fact to resolve.

The Board remands the claims for an eye condition and prostate cancer as secondary to radiation exposure due to inadequate medical opinions and non-compliance with previous remand directives.

The appeal for service connection for diabetes mellitus type 2 and prostate cancer was withdrawn by the appellant's authorized representative, and these issues are dismissed.

The Board granted presumptive service connection for prostate cancer, and service connection for erectile dysfunction and incontinence as secondary to the service-connected prostate cancer.

The Board granted service connection for asthma, but remanded the claims for ischemic heart disease and prostate cancer due to duty-to-assist errors.

The Board denied service connection for prostate cancer residuals, finding that the evidence does not support a link between the condition and active duty training.

The Board granted service connection for bilateral hearing loss disability and tinnitus, but denied service connection for heart disability and prostate cancer.

The Board remands the claims for service connection due to new and relevant evidence having been received since a previous denial.

The Board granted an initial rating of 60 percent for prostate cancer residuals prior to November 14, 2024, but denied a higher rating since that date.

The Board found that the reduction in evaluation of prostate cancer residuals from 100 percent to 20 percent effective August 1, 2024, was proper.

The Veteran was granted special monthly compensation (SMC) based on the need for aid and attendance due to a service-connected prostate disability.

The Board granted service connection for pulmonary nodules and remanded the claims for hypertension, thyroid nodules, valvular heart disease, cataracts, prostate cancer, and erectile dysfunction due to missing records and inadequate opinions.

The appeal of the denial of service connection for right ankle disability, tinnitus, and PTSD was dismissed due to an untimely Notice of Disagreement.

The Board granted service connection for residuals of prostate cancer and ED, secondary to the service-connected residuals of prostate cancer.

The Board denied the veteran's claims for increased ratings and initial compensable ratings for prostate cancer, erectile dysfunction, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy.

The Board denied an initial compensable rating for bilateral sensorineural hearing loss and remanded the claims for service connection for prostate cancer, lumbosacral strain, and a higher rating for TBI.

The Board granted service connection for prostate cancer and erectile dysfunction as secondary to the prostate cancer.

The Board granted presumptive service connection for residuals of prostate cancer under the PACT Act due to the Veteran's presumed exposure to burn pit toxins during his service in Kuwait.